Table 5. Linear mixed-effects models for assessing impact of lesion features on relative difference in SUV metrics.
Model | SUV metric | Fixed effect | beta | std error | t statistic | p-value | |
---|---|---|---|---|---|---|---|
V1 | SUVmean | Base | ref | ||||
Original SUVmean | −0.636 | 0.172 | −3.71 | 2.56E-04 | |||
HUmean | 0.020 | 0.014 | 1.42 | 0.154 | |||
HUmax | 1.20E-04 | 5.69E-05 | 2.11 | 0.035 | |||
Volume | −0.128 | 0.122 | −1.04 | 0.296 | |||
Location | Bone | 6.79 | 4.99 | 1.36 | 0.075 | ||
Other | 30.9 | 17.7 | 1.75 | ||||
Prostate | 12.2 | 6.35 | 1.92 | ||||
PSMARADS | 5 | −8.20 | 3.80 | −2.16 | 0.032 | ||
SUVmax | Base | ref | |||||
Original | −0.384 | 0.101 | −3.80 | 1.78E-04 | |||
HUmean | 0.027 | 0.014 | 1.85 | 0.065 | |||
HUmax | 0.014 | 0.006 | 2.36 | 0.019 | |||
Volume | −0.141 | 0.129 | −1.10 | 0.273 | |||
Location | Bone | 11.4 | 5.22 | 2.19 | 0.060 | ||
Other | 32.1 | 18.5 | 1.73 | ||||
Prostate | 6.38 | 6.63 | 0.962 | ||||
PSMARADS | 5 | −10.9 | 3.97 | −2.74 | 0.007 | ||
V2 | SUVmean | Base | ref | ||||
Original SUVmean | −0.410 | 0.190 | −2.15 | 3.20E-02 | |||
HUmean | 0.023 | 0.015 | 1.55 | 0.120 | |||
HUmax | 0.013 | 0.006 | 2.06 | 0.040 | |||
Volume | −0.134 | 0.133 | −1.01 | 0.314 | |||
Location | Bone | 9.21 | 5.40 | 1.71 | 0.084 | ||
Other | 37.9 | 19.2 | 1.97 | ||||
Prostate | 7.47 | 6.86 | 1.09 | ||||
PSMARADS | 5 | −9.56 | 4.13 | −2.32 | 0.021 | ||
SUVmax | Base | ref | |||||
Original | −0.252 | 0.119 | −2.12 | 3.51E-02 | |||
HUmean | 0.019 | 0.017 | 1.14 | 0.253 | |||
HUmax | 0.011 | 0.007 | 1.53 | 0.127 | |||
Volume | −0.147 | 0.149 | −0.986 | 0.324 | |||
Location | Bone | 10.4 | 6.00 | 1.73 | 0.059 | ||
Other | 39.7 | 21.4 | 1.86 | ||||
Prostate | −0.313 | 7.61 | −0.411 | ||||
PSMARADS | 5 | −7.92 | 4.63 | −1.71 | 0.088 |
Base model: Rel.Diff ~ (1|patient). Evaluated models: Rel.Diff ~ <variable> + (1|patient). Statistical significance relative to base model determined from ANOVA.